ATE212543T1 - Pharmazeutische zusammensetzung aus stabilisierten lipophilen matrizen mit kontrollierter wirkstofffreisetzung - Google Patents
Pharmazeutische zusammensetzung aus stabilisierten lipophilen matrizen mit kontrollierter wirkstofffreisetzungInfo
- Publication number
- ATE212543T1 ATE212543T1 AT97400990T AT97400990T ATE212543T1 AT E212543 T1 ATE212543 T1 AT E212543T1 AT 97400990 T AT97400990 T AT 97400990T AT 97400990 T AT97400990 T AT 97400990T AT E212543 T1 ATE212543 T1 AT E212543T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- controlled release
- active ingredients
- lipophilic matrices
- stabilized
- Prior art date
Links
- 238000013270 controlled release Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 239000011159 matrix material Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9605606A FR2748209B1 (fr) | 1996-05-06 | 1996-05-06 | Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE212543T1 true ATE212543T1 (de) | 2002-02-15 |
Family
ID=9491845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97400990T ATE212543T1 (de) | 1996-05-06 | 1997-05-02 | Pharmazeutische zusammensetzung aus stabilisierten lipophilen matrizen mit kontrollierter wirkstofffreisetzung |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0806202B1 (de) |
| JP (1) | JP3983339B2 (de) |
| CN (1) | CN1171270A (de) |
| AT (1) | ATE212543T1 (de) |
| AU (1) | AU720146B2 (de) |
| CA (1) | CA2204475C (de) |
| DE (1) | DE69710121T2 (de) |
| DK (1) | DK0806202T3 (de) |
| ES (1) | ES2170922T3 (de) |
| FR (1) | FR2748209B1 (de) |
| HU (1) | HU222045B1 (de) |
| NO (1) | NO318227B1 (de) |
| NZ (1) | NZ314740A (de) |
| PL (1) | PL190562B1 (de) |
| PT (1) | PT806202E (de) |
| ZA (1) | ZA973836B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1011363A3 (fr) * | 1997-09-11 | 1999-08-03 | Smb Technology | Capsules semi-solides autoemulsionnables matricielles a action prolongee. |
| FR2782006B1 (fr) * | 1998-08-07 | 2002-04-19 | Gattefosse Ets Sa | Composition a liberation prolongee apte a former une micro-emulsion |
| DE10161078A1 (de) * | 2001-12-12 | 2003-08-28 | Achim Goepferich | Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen |
| US8084054B2 (en) * | 2002-07-15 | 2011-12-27 | Novartis Ag | Bioerodible film for ophthalmic drug delivery |
| CN102552917A (zh) | 2003-08-13 | 2012-07-11 | 比奥孔有限公司 | 用于治疗剂的微-粒子脂肪酸盐固体剂量制剂 |
| GB0324574D0 (en) * | 2003-10-21 | 2003-11-26 | Glaxo Group Ltd | Novel compositions |
| EP1959935A2 (de) | 2005-10-26 | 2008-08-27 | Banner Pharmacaps Inc. | Hydrophiles matrixsystem mit doppelter freisetzungskontrolle auf vehikelbasis als kapselfüllung |
| CN101351196B (zh) * | 2005-10-26 | 2013-07-03 | 班纳制药公司 | 作为胶囊填充物的基于亲脂性载体的双重控释基质系统 |
| US8198268B2 (en) | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
| JP2013119540A (ja) * | 2011-12-08 | 2013-06-17 | Nipro Corp | 固形医薬組成物およびその製造法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797286A (en) * | 1985-11-12 | 1989-01-10 | Eli Lilly And Company | Orally administerable sustained release pharmaceutical formulations |
| DE4413350A1 (de) * | 1994-04-18 | 1995-10-19 | Basf Ag | Retard-Matrixpellets und Verfahren zu ihrer Herstellung |
| US5545628A (en) * | 1995-01-10 | 1996-08-13 | Galephar P.R. Inc. | Pharmaceutical composition containing fenofibrate |
-
1996
- 1996-05-06 FR FR9605606A patent/FR2748209B1/fr not_active Expired - Fee Related
-
1997
- 1997-05-02 PT PT97400990T patent/PT806202E/pt unknown
- 1997-05-02 DE DE69710121T patent/DE69710121T2/de not_active Expired - Lifetime
- 1997-05-02 ES ES97400990T patent/ES2170922T3/es not_active Expired - Lifetime
- 1997-05-02 AT AT97400990T patent/ATE212543T1/de active
- 1997-05-02 EP EP97400990A patent/EP0806202B1/de not_active Expired - Lifetime
- 1997-05-02 DK DK97400990T patent/DK0806202T3/da active
- 1997-05-05 HU HU9700842A patent/HU222045B1/hu not_active IP Right Cessation
- 1997-05-05 NO NO19972068A patent/NO318227B1/no not_active IP Right Cessation
- 1997-05-05 CN CN97109780A patent/CN1171270A/zh active Pending
- 1997-05-05 ZA ZA9703836A patent/ZA973836B/xx unknown
- 1997-05-05 NZ NZ314740A patent/NZ314740A/en not_active IP Right Cessation
- 1997-05-05 PL PL97319808A patent/PL190562B1/pl not_active IP Right Cessation
- 1997-05-05 CA CA002204475A patent/CA2204475C/fr not_active Expired - Fee Related
- 1997-05-05 AU AU19991/97A patent/AU720146B2/en not_active Ceased
- 1997-05-06 JP JP11554897A patent/JP3983339B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2170922T3 (es) | 2002-08-16 |
| AU1999197A (en) | 1997-11-13 |
| FR2748209B1 (fr) | 1998-06-05 |
| NO318227B1 (no) | 2005-02-21 |
| CA2204475C (fr) | 2002-12-03 |
| AU720146B2 (en) | 2000-05-25 |
| ZA973836B (en) | 1997-12-02 |
| HUP9700842A1 (hu) | 1998-08-28 |
| EP0806202B1 (de) | 2002-01-30 |
| NO972068L (no) | 1997-11-07 |
| HU222045B1 (hu) | 2003-04-28 |
| HU9700842D0 (en) | 1997-06-30 |
| NO972068D0 (no) | 1997-05-05 |
| EP0806202A1 (de) | 1997-11-12 |
| CN1171270A (zh) | 1998-01-28 |
| DE69710121T2 (de) | 2002-11-28 |
| PL319808A1 (en) | 1997-11-10 |
| JP3983339B2 (ja) | 2007-09-26 |
| DK0806202T3 (da) | 2002-05-06 |
| PT806202E (pt) | 2002-06-28 |
| NZ314740A (en) | 1998-11-25 |
| CA2204475A1 (fr) | 1997-11-06 |
| FR2748209A1 (fr) | 1997-11-07 |
| PL190562B1 (pl) | 2005-12-30 |
| DE69710121D1 (de) | 2002-03-14 |
| JPH1045629A (ja) | 1998-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0350246A3 (en) | Sustained release microcapsule for water soluble drug | |
| DK0841903T3 (da) | Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol | |
| DE3868037D1 (de) | Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe. | |
| ATE324104T1 (de) | Mesalazine enthaltende pharmazeutische zusammensetzungen mit gesteuerter freisetzung | |
| NZ515230A (en) | Fast-dispersing dosage forms containing fish gelatin | |
| ATA223488A (de) | Bioerodierbare pharmazeutische zusammensetzung fuer anhaltende und kontrollierte polypeptid-wirkstofffreigabe | |
| DE69323442D1 (de) | Flüssige pharmazeutische Formulierung mit verlängerter Wirkstoffabgabe | |
| MX9304710A (es) | Composicion farmaceutica y/o cosmetica y su uso. | |
| NO304261B1 (no) | Preparat omfattende en lipofil forbindelse | |
| ATE212543T1 (de) | Pharmazeutische zusammensetzung aus stabilisierten lipophilen matrizen mit kontrollierter wirkstofffreisetzung | |
| ATE220321T1 (de) | Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe | |
| DE59804823D1 (de) | Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung | |
| DE59907481D1 (de) | Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff | |
| SE8804628D0 (sv) | New compounds | |
| ATE272405T1 (de) | Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine | |
| ATE97572T1 (de) | Azelastin enthaltende arzneimittel mit kontrollierter wirkstoffabgabe. | |
| NO894467D0 (no) | Reservoar for styrt frigjoering av aktive substanser, anordning som inneholder den, fremgangsmaate for aa fremstille den, og bruk av anordningen. | |
| HRP20000781B1 (hr) | Šumeći pripravci | |
| DE69012031D1 (de) | Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung. | |
| ATA124091A (de) | Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz | |
| DE69416034D1 (de) | Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen | |
| ATE78161T1 (de) | 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung. | |
| DE68907091D1 (de) | Scleroglucan und wirkstoff enthaltende pharmazeutische tabletten und kapselgranulate. | |
| EP0305194A3 (de) | Tierärztliche Zusammensetzung | |
| ATE77820T1 (de) | Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |